Clinical Trial: A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07639905) titled 'A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets' on June 05.

Brief Summary: This study is a single-center, single-dose, randomized, open-label, two-period, crossover phase I clinical trial, comparing the bioavailability and safety of the new and old processes of HRS-2189 tablets in healthy subjects.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Malignant Solid Tumor

Intervention: DRUG: HRS-2189 Tablet

HRS-2189 tablet, oral.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shandong Suncadia Medicine Co., Ltd.

Disclaimer: Curated by HT Syndication....